Massachusetts Financial Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.62B | Buy |
56,911,830
+1,038,828
| +2% | +$27.7M | 0.54% | 47 |
|
|
2025
Q4 | $1.39B | Sell |
55,873,002
-1,715,658
| -3% | -$43.3M | 0.45% | 66 |
|
|
2025
Q3 | $1.47B | Sell |
57,588,660
-17,885,662
| -24% | -$441M | 0.45% | 65 |
|
|
2025
Q2 | $1.83B | Buy |
75,474,322
+27,964
| +0% | +$652K | 0.58% | 46 |
|
|
2025
Q1 | $1.91B | Sell |
75,446,358
-1,055,880
| -1% | -$27.6M | 0.64% | 39 |
|
|
2024
Q4 | $2.03B | Buy |
76,502,238
+5,350,381
| +8% | +$145M | 0.64% | 33 |
|
|
2024
Q3 | $2.06B | Sell |
71,151,857
-642,199
| -0.9% | -$18.7M | 0.62% | 39 |
|
|
2024
Q2 | $2.01B | Buy |
71,794,056
+2,241,609
| +3% | +$61.7M | 0.62% | 36 |
|
|
2024
Q1 | $1.93B | Buy |
69,552,447
+1,046,006
| +2% | +$29M | 0.58% | 44 |
|
|
2023
Q4 | $1.97B | Buy |
68,506,441
+8,298,920
| +14% | +$251M | 0.64% | 37 |
|
|
2023
Q3 | $2B | Buy |
60,207,521
+5,185,453
| +9% | +$183M | 0.7% | 32 |
|
|
2023
Q2 | $2.02B | Buy |
55,022,068
+984,908
| +2% | +$38.3M | 0.66% | 37 |
|
|
2023
Q1 | $2.2B | Buy |
54,037,160
+4,754,795
| +10% | +$205M | 0.75% | 28 |
|
|
2022
Q4 | $2.53B | Buy |
49,282,365
+7,938,347
| +19% | +$381M | 0.88% | 23 |
|
|
2022
Q3 | $1.81B | Sell |
41,344,018
-913,582
| -2% | -$44.4M | 0.68% | 38 |
|
|
2022
Q2 | $2.22B | Sell |
42,257,600
-1,133,519
| -3% | -$57.8M | 0.76% | 33 |
|
|
2022
Q1 | $2.25B | Buy |
43,391,119
+9,537,621
| +28% | +$495M | 0.67% | 40 |
|
|
2021
Q4 | $2B | Sell |
33,853,498
-109,340
| -0.3% | -$5.42M | 0.55% | 49 |
|
|
2021
Q3 | $1.46B | Sell |
33,962,838
-341,198
| -1% | -$15.1M | 0.43% | 62 |
|
|
2021
Q2 | $1.34B | Sell |
34,304,036
-996,075
| -3% | -$38.7M | 0.39% | 69 |
|
|
2021
Q1 | $1.28B | Sell |
35,300,111
-396,070
| -1% | -$14.1M | 0.39% | 68 |
|
|
2020
Q4 | $1.31B | Sell |
35,696,181
-4,548,761
| -11% | -$167M | 0.42% | 64 |
|
|
2020
Q3 | $1.4B | Sell |
40,244,942
-1,484,768
| -4% | -$52.1M | 0.51% | 49 |
|
|
2020
Q2 | $1.29B | Buy |
41,729,710
+412,987
| +1% | +$14M | 0.51% | 51 |
|
|
2020
Q1 | $1.28B | Sell |
41,316,723
-13,303,190
| -24% | -$453M | 0.61% | 42 |
|
|
2019
Q4 | $2.03B | Sell |
54,619,913
-3,403,797
| -6% | -$121M | 0.76% | 36 |
|
|
2019
Q3 | $1.98B | Sell |
58,023,710
-648,604
| -1% | -$23.6M | 0.79% | 33 |
|
|
2019
Q2 | $2.41B | Sell |
58,672,314
-1,128,075
| -2% | -$44.8M | 0.98% | 19 |
|
|
2019
Q1 | $2.41B | Buy |
59,800,389
+466,580
| +0.8% | +$18.7M | 1.02% | 19 |
|
|
2018
Q4 | $2.46B | Sell |
59,333,809
-4,046,841
| -6% | -$168M | 1.18% | 14 |
|
|
2018
Q3 | $2.65B | Sell |
63,380,650
-1,842,219
| -3% | -$70.9M | 1.09% | 16 |
|
|
2018
Q2 | $2.25B | Buy |
65,222,869
+169,409
| +0.3% | +$5.79M | 0.96% | 23 |
|
|
2018
Q1 | $2.19B | Buy |
65,053,460
+937,105
| +1% | +$32.2M | 0.94% | 24 |
|
|
2017
Q4 | $2.2B | Sell |
64,116,355
-876,552
| -1% | -$29.9M | 0.92% | 28 |
|
|
2017
Q3 | $2.2B | Buy |
64,992,907
+3,861,362
| +6% | +$124M | 0.96% | 24 |
|
|
2017
Q2 | $1.95B | Buy |
61,131,545
+440,375
| +0.7% | +$13.9M | 0.86% | 32 |
|
|
2017
Q1 | $1.97B | Buy |
60,691,170
+11,023,702
| +22% | +$348M | 0.92% | 24 |
|
|
2016
Q4 | $1.53B | Sell |
49,667,468
-3,246,631
| -6% | -$99.1M | 0.75% | 38 |
|
|
2016
Q3 | $1.7B | Buy |
52,914,099
+375,716
| +0.7% | +$12.6M | 0.83% | 30 |
|
|
2016
Q2 | $1.76B | Buy |
52,538,383
+982,220
| +2% | +$31.3M | 0.88% | 28 |
|
|
2016
Q1 | $1.45B | Sell |
51,556,163
-4,026,134
| -7% | -$115M | 0.75% | 33 |
|
|
2015
Q4 | $1.7B | Sell |
55,582,297
-3,275,325
| -6% | -$103M | 0.91% | 23 |
|
|
2015
Q3 | $1.75B | Sell |
58,857,622
-5,187,562
| -8% | -$166M | 0.98% | 24 |
|
|
2015
Q2 | $2.04B | Sell |
64,045,184
-810,184
| -1% | -$26.4M | 1.04% | 23 |
|
|
2015
Q1 | $2.14B | Sell |
64,855,368
-5,744,893
| -8% | -$183M | 1.08% | 23 |
|
|
2014
Q4 | $2.09B | Sell |
70,600,261
-13,252,896
| -16% | -$380M | 1.06% | 23 |
|
|
2014
Q3 | $2.35B | Sell |
83,853,157
-4,688,993
| -5% | -$132M | 1.24% | 17 |
|
|
2014
Q2 | $2.49B | Sell |
88,542,150
-1,903,581
| -2% | -$54.3M | 1.3% | 17 |
|
|
2014
Q1 | $2.76B | Buy |
90,445,731
+1,133,407
| +1% | +$33.8M | 1.51% | 12 |
|
|
2013
Q4 | $2.6B | Sell |
89,312,324
-1,031,793
| -1% | -$30M | 1.46% | 14 |
|
|
2013
Q3 | $2.46B | Buy |
90,344,117
+173,870
| +0.2% | +$4.73M | 1.52% | 12 |
|
|
2013
Q2 | $2.4B | Buy |
+90,170,247
| New | +$2.49B | 1.62% | 11 |
|
Other funds holding PFE
VCM
VPM
Massachusetts Financial Services's PFE Position: Q1 2026 in Review
Massachusetts Financial Services increased its Pfizer (PFE) stake by 1.9% in Q1 2026, buying an estimated $27.7M and bringing the position to 56,911,830 shares worth $1.62B. The position accounts for 0.54% of the portfolio, ranked #47.
Massachusetts Financial Services first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.76B in Q1 2014. 2,938 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Massachusetts Financial Services held 56,911,830 shares of Pfizer worth $1.62B as of Q1 2026.
- Massachusetts Financial Services bought 1,038,828 Pfizer shares in Q1 2026, an estimated $27.7M.
- Pfizer made up 0.54% of Massachusetts Financial Services's portfolio in Q1 2026, its #47 holding.
- Massachusetts Financial Services first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Massachusetts Financial Services's Pfizer position peaked at $2.76B in Q1 2014.
- 2,938 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Massachusetts Financial Services's 13F filing for Q1 2026, filed 14 May 2026.